NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1119,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "33592b07-1e5f-490a-bf99-f53cc0501b1b",
"title": "AstraZeneca: rachat de Fusion dans l'oncologie de précision",
"description": "AstraZeneca a annoncé mardi qu'il allait prendre le contrôle de la société canadienne Fusion Pharmaceuticals, spécialisée dans les médicaments de préc - 19/03/2024 09:57",
"keywords": "",
"snippet": "(CercleFinance.com) - AstraZeneca a annoncé mardi qu'il allait prendre le contrôle de la société canadienne Fusion Pharmaceuticals, spécialisée dans les m...",
"url": "https://www.abcbourse.com/marches/astrazeneca-rachat-de-fusion-dans-l-oncologie-de-precision_625146",
"image_url": "https://www.abcbourse.com/imgabc/208-c.jpg",
"language": "fr",
"published_at": "2024-03-19T09:57:00.000000Z",
"source": "abcbourse.com",
"relevance_score": null,
"entities": [
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.790344,
"sentiment_score": null,
"highlights": [
{
"highlight": "(CercleFinance.com) - <em>AstraZeneca</em> a annoncé mardi qu'il allait prendre le contrôle de la société canadienne Fusion Pharmaceuticals, spécialisée dans les médicaments de précision contre le cancer, dans le cadre d'une transaction pouvant atteindre 2,4 milliards de dollars.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Dans le détail, <em>AstraZeneca</em> va proposer 21 dollars par titre en numéraire aux actionnaires de Fusion Pharmaceuticals, qui cote sur le Nasdaq, à comparer avec un cours de clôture de 10,6 dollars hier soir.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em>: rachat de Fusion dans l'oncologie de précision",
"sentiment": 0.6486,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5e4b9542-ea7a-43bf-aeda-ff491b09ae77",
"title": "Biggest stock movers today: FUSN, NCMI, crypto stocks and more (NASDAQ:STNE)",
"description": "Stock futures were trading mixed in the early hours of Tuesday as market participants eagerly await cues on the future path of interest rates as the Federal Res",
"keywords": "",
"snippet": "Stock futures were largely unchanged in the early hours of Tuesday as market participants eagerly await cues on the future path of interest rates as the Federal...",
"url": "https://seekingalpha.com/news/4080871-biggest-stock-movers-today-fusn-ncmi-and-more",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/506910800/image_506910800.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2024-03-19T09:43:23.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.514778,
"sentiment_score": 0.32435,
"highlights": [
{
"highlight": "Fusion Pharmaceuticals ( NASDAQ: FUSN urged 94% following the announcement of its acquisition by <em>AstraZeneca</em> (AZN) for $21.00 per share in cash at closing, along with a contingent value right of $3.00 per share in cash contingent on achieving a specified regulatory milestone.",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "The deal is expected to close in 2Q24 and will bring new expertise and capabilities in actinium-based radio conjugates to <em>AstraZeneca</em>, strengthening its presence in Canada.\n\nBiggest stock losers",
"sentiment": -0.0516,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "6da6a6bf-c15e-4689-a8a6-7d433c30dbc9",
"title": "Futures tread water ahead of Fed meet By Reuters",
"description": "Futures tread water ahead of Fed meet",
"keywords": "",
"snippet": "Published Mar 19, 2024 05:36AM ET Updated Mar 19, 2024 05:42AM ET\n\n© Reuters. Traders work on the floor at the New York Stock Exchange (NYSE) in New York City,...",
"url": "https://www.investing.com/news/stock-market-news/futures-tread-water-ahead-of-fed-meet-3343429",
"image_url": "https://i-invdn-com.investing.com/news/LYNXNPEAAP0BV_L.jpg",
"language": "en",
"published_at": "2024-03-19T09:42:09.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 15.257277,
"sentiment_score": 0.4728,
"highlights": [
{
"highlight": "Wall Street closed higher on Monday, with the Nasdaq bouncing back from two small weekly losses, as growth stocks such as <em>Alphabet</em> (NASDAQ: ) and Tesla (NASDAQ: ) boosted the tech-heavy index.\n\nMost megacap growth stocks edged lower in premarket trading.",
"sentiment": 0.4728,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "22229ca0-0c04-4dd7-a085-86a98e5ed957",
"title": "Ross Gerber Says 'Apple Using Google AI (Which Still Sucks) On iPhones In A Sad Admission They Missed Another Boat' - Alphabet (NASDAQ:GOOG), Apple (NASDAQ:AAPL)",
"description": "Apple was reportedly in discussions with Google to license Gemini, a set of generative AI models, to power new iPhone software features.",
"keywords": "",
"snippet": "Loading... Loading...\n\nTesla investor Ross Gerber on Monday criticized Apple Inc.’s AAPL reported deal with Google GOOGL GOOG.\n\nWhat Happened: Gerber said the...",
"url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37815038/ross-gerber-says-apple-using-google-ai-which-still-sucks-on-iphones-in-a-sad-admiss",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/San-Francisco--Usa---Oct-5--2015-Apple-S_3.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-03-19T09:37:12.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 47.713127,
"sentiment_score": -0.00696,
"highlights": [
{
"highlight": "Tesla investor Ross Gerber on Monday criticized <em>Apple</em> <em>Inc</em>.’s AAPL reported deal with Google GOOGL GOOG.\n\nWhat Happened: Gerber said the deal is a “sad admission” of missed opportunities, while commenting on the robust performance of tech stocks in the early trading hours.\n\n“Stocks pop on AI dreams of a massive upgrade in technology.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> using Google AI (which still sucks) on iPhones in a sad admission they missed another boat,” Gerber wrote.\n\n<em>Apple</em> is reportedly in discussions with Google to license Gemini, a set of generative AI models, to power new iPhone software features. This potential deal would build on the existing search partnership between the two tech giants.",
"sentiment": -0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Deepwater Asset Management’s managing partner Gene Munster believes that this deal could position <em>Apple</em> as a leader in personalized AI.\n\nOn the other hand, billionaire investor Chamath Palihapitiya has suggested that Apple’s move to license generative AI models from Google and OpenAI could indicate a shift in the company’s approach to AI.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Wedbush’s Dan Ives has also highlighted the potential partnership between <em>Apple</em> and Google as a crucial element in Apple's AI strategy, which could significantly enhance the company's AI capabilities.\n\nPrice Action: Despite pessimism from Gerber, <em>Apple</em> stock closed 0.64% higher at $173.72, according to data from Benzinga Pro.",
"sentiment": 0.1128,
"highlighted_in": "main_text"
},
{
"highlight": "Ross Gerber Says '<em>Apple</em> Using Google AI (Which Still Sucks) On iPhones In A Sad Admission They Missed Another Boat' - Alphabet (NASDAQ:GOOG), <em>Apple</em> (<em>NASDAQ:AAPL</em>)",
"sentiment": -0.6486,
"highlighted_in": "title"
}
]
},
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 24.00879,
"sentiment_score": -0.6486,
"highlights": [
{
"highlight": "Ross Gerber Says 'Apple Using Google AI (Which Still Sucks) On iPhones In A Sad Admission They Missed Another Boat' - Alphabet (<em>NASDAQ:GOOG</em>), Apple (NASDAQ:AAPL)",
"sentiment": -0.6486,
"highlighted_in": "title"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 27.791553,
"sentiment_score": -0.0949,
"highlights": [
{
"highlight": "Tesla investor Ross Gerber on Monday criticized Apple Inc.’s AAPL reported deal with Google <em>GOOGL</em> GOOG.\n\nWhat Happened: Gerber said the deal is a “sad admission” of missed opportunities, while commenting on the robust performance of tech stocks in the early trading hours.\n\n“Stocks pop on AI dreams of a massive upgrade in technology.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ross Gerber Says 'Apple Using Google AI (Which Still Sucks) On iPhones In A Sad Admission They Missed Another Boat' - <em>Alphabet</em> (NASDAQ:GOOG), Apple (NASDAQ:AAPL)",
"sentiment": -0.6486,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "14f61859-4024-4c4b-9336-d2e5e1477c60",
"title": "This Is the Cheapest \"Magnificent Seven\" Stock, According to Peter Lynch's Favorite Valuation Metric",
"description": "This measure accounts for both valuation and growth.",
"keywords": "",
"snippet": "There's been a lot of talk about the \"Magnificent Seven\" stocks recently. These large, competitively advantaged tech platforms have vastly outperformed the mark...",
"url": "https://www.fool.com/investing/2024/03/19/cheapest-magnificent-seven-stock-peter-lynch/",
"image_url": "https://g.foolcdn.com/editorial/images/769603/gettyimages-1463088844.jpg",
"language": "en",
"published_at": "2024-03-19T09:36:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 13.5167,
"sentiment_score": 0.12855,
"highlights": [
{
"highlight": "Company PEG Ratio Meta Platforms (META 2.66%) 1.10 Nvidia (NVDA 0.70%) 1.36 <em>Alphabet</em> (<em>GOOGL</em> 4.60%) (GOOG 4.44%) 1.49 Tesla (TSLA 6.25%) 1.93 Microsoft (MSFT 0.22%) 2.11 Apple (AAPL 0.64%) 2.12 Amazon (AMZN 0.03%) 2.36\n\nThere are a few expected results here, but also a few surprises.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "First, it's not surprising to see both Meta and <em>Alphabet</em> among the cheapest of these stocks. These two generally trade at discounts to other \"disruptive\" tech names, perhaps because of their already being large, \"mature\" companies.",
"sentiment": -0.0829,
"highlighted_in": "main_text"
},
{
"highlight": "Still, that has been the case for years, and both <em>Alphabet</em> and Meta have generally been able to defy skeptics and continue solid growth over the long term as ad dollars continue to flow to digital ads from traditional advertisements.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "In addition, <em>Alphabet</em> has lots of cash on its balance sheet and generates significant losses from its \"Other Bets\" segment, increasing its P/E ratio relative to its core business and making it look more expensive.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "814b9786-877e-4bcd-aad0-27a231b046e8",
"title": "Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results",
"description": "Cash Position: Maintained a stable cash reserve with $52.6 million as of December 31, 2023.Revenue Growth: Year-over-year increase in license and other revenue",
"keywords": "GuruFocus, Article, News, GuruFocus Research, ABEO",
"snippet": "Abeona Therapeutics Inc (ABEO, Financial) released its 8-K filing on March 18, 2024, detailing the company's financial results for the full year of 2023 and ann...",
"url": "https://www.gurufocus.com/news/2385956/abeona-therapeutics-inc-abeo-reports-full-year-2023-financial-results",
"image_url": "https://static.gurufocus.com/logos/0C0000097E.png?5",
"language": "en",
"published_at": "2024-03-19T09:31:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABEO",
"name": "Abeona Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 147.92134,
"sentiment_score": 0.0923,
"highlights": [
{
"highlight": "<em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> (ABEO, Financial) released its 8-K filing on March 18, 2024, detailing the company's financial results for the full year of 2023 and announcing the completion of critical FDA inspections.",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Abeona</em> <em>Therapeutics</em>, a clinical-stage biopharmaceutical company, is at the forefront of developing gene therapies and plasma-based products for rare genetic diseases, with a focus on its lead clinical programs EB-101, ABO-102, and ABO-101.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Abeona</em> <em>Therapeutics</em> will host a conference call and webcast to discuss these financial results and provide updates on corporate progress. Investors and stakeholders are encouraged to participate or access the archived webcast to gain further insights into the company's performance and future prospects.",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "As <em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> (ABEO, Financial) navigates through these pivotal moments, the company's financial results and regulatory achievements in 2023 serve as a testament to its strategic focus and operational execution.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> (ABEO) Reports Full Year 2023 Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "ba477e30-c947-4f0a-8c89-72a74159bc28",
"title": "Q4 2023 Abeona Therapeutics Inc Earnings Call Transcript",
"description": "Mar 18, 2024 / 12:30PM GMTOperator Good morning, everyone, and welcome to AB. IONA's Fourth Quarter and Full Year 2023 earnings conference call. At this time, a",
"keywords": "GuruFocus, Article, News, GuruFocus Research, NAS:ABEO",
"snippet": "Mar 18, 2024 / 12:30PM GMT\n\nOperator\n\n\n\nGood morning, everyone, and welcome to AB. IONA's Fourth Quarter and Full Year 2023 earnings conference call. At this ti...",
"url": "https://www.gurufocus.com/news/2385899/q4-2023-abeona-therapeutics-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-03-19T05:00:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABEO",
"name": "Abeona Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 159.43906,
"sentiment_score": 0.32985,
"highlights": [
{
"highlight": "Greg Gin - <em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> - VP, IR & Corporate Communications\n\n\n\nThank you, Jenny, and good morning, everyone.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2023 <em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0H7R.L",
"name": "Abeona Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 159.4097,
"sentiment_score": 0.32985,
"highlights": [
{
"highlight": "Greg Gin - <em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> - VP, IR & Corporate Communications\n\n\n\nThank you, Jenny, and good morning, everyone.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2023 <em>Abeona</em> <em>Therapeutics</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "54f67f34-6786-4be6-84a3-7a7ae73665e0",
"title": "News Highlights : Top Global Markets News of the Day - Tuesday at 5 AM ET -March 19, 2024 at 05:16 am EDT",
"description": "Bank of Japan Ends Negative Interest Rates \n \n\n The global era of minus rates ended as the Japanese central bank ended an eight-year run in negative territory and rolled back most of its...",
"keywords": "Markets",
"snippet": "Bank of Japan Ends Negative Interest Rates\n\nThe global era of minus rates ended as the Japanese central bank ended an eight-year run in negative territory and r...",
"url": "https://www.marketscreener.com/quote/currency/AUSTRALIAN-DOLLAR-US-DOLL-2373531/news/News-Highlights-Top-Global-Markets-News-of-the-Day-Tuesday-at-5-AM-ET-46228655/",
"image_url": "https://www.marketscreener.com/images/reuters/2017-02-23T005601Z_1006950001_LYNXMPED1M02Y_RTROPTP_2_CBUSINESS-US-GLOBAL-FOREX.JPG",
"language": "en",
"published_at": "2024-03-19T09:16:31.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 12.381352,
"sentiment_score": 0.0516,
"highlights": [
{
"highlight": "<em>Alphabet</em>, Tesla Power Stock Indexes Higher\n\nThe gains come despite scaled-back bets on the Fed's interest-rate cuts. The S&P 500 rises 0.6%, while the tech-heavy Nasdaq Composite advances 0.8%.",
"sentiment": 0.0516,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "5a30a5fe-09de-4e87-873c-9b6b96c8c882",
"title": "BOJ hike, Fed meeting, Nvidia conference, Bitcoin",
"description": "BOJ hike, Fed meeting, Nvidia conference, Bitcoin - what's moving markets",
"keywords": "",
"snippet": "Published Mar 19, 2024 05:05AM ET Updated Mar 19, 2024 05:16AM ET\n\nBA -1.44% Add to/Remove from Watchlist MSFT +0.22% Add to/Remove from Watchlist AAPL +0.64% A...",
"url": "https://www.investing.com/news/economy/boj-hike-fed-meeting-nvidia-conference-bitcoin--whats-moving-markets-3343380",
"image_url": "https://i-invdn-com.investing.com/news/wallstreet_3_800x533_L_1412692164.jpg",
"language": "en",
"published_at": "2024-03-19T09:16:19.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 8.750399,
"sentiment_score": 0.5423,
"highlights": [
{
"highlight": "However, Nvidia stock fell over 1% premarket as these announcements failed to attract new investors given the extent of the rally which has seen the shares surge 240% over the past 12 months, making it the U.S. stock market's third-most valuable company, behind only Microsoft (NASDAQ: ) and <em>Apple</em> (NASDAQ: ).",
"sentiment": 0.5423,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a49193fe-627b-41f4-a4cb-b67f4cb3c777",
"title": "S|W: The SaaS Weekly – The US could ban TikTok. Will Canada follow?",
"description": "Plus: MDF commerce agrees to go private, but some shareholders raise a fuss.",
"keywords": "tiktok, mdf commerce, kkr, saas, pitchbook, truecontext, reddit, yamaha motors, joyride, oracle, devops, codezero, telegram, beatconnect",
"snippet": "Plus: MDF commerce agrees to go private, but some shareholders raise a fuss.\n\nThe SaaS Weekly is a weekly newsletter covering major SaaS news from Canada and ar...",
"url": "https://betakit.com/sw-the-saas-weekly-the-us-could-ban-tiktok-will-canada-follow/",
"image_url": "https://cdn.betakit.com/wp-content/uploads/2023/02/TikTok.jpg",
"language": "en",
"published_at": "2024-03-19T09:08:08.000000Z",
"source": "betakit.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMZN",
"name": "Amazon.com, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.261798,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "The Austin-based company, known for its database software, is focused on expanding its cloud infrastructure business to compete with <em>Amazon.com</em> <em>Inc</em>., Microsoft Corp. and Alphabet Inc.’s Google. That effort has faced headwinds in recent quarters as growth rates slowed.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 7.932468,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "., Microsoft Corp. and <em>Alphabet</em> <em>Inc</em>.’s Google. That effort has faced headwinds in recent quarters as growth rates slowed.\n\n(BNN Bloomberg)\n\nVancouver-based developer operations platform Codezero has secured $3.5 million in seed funding.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 12.411467,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "., Microsoft Corp. and <em>Alphabet</em> <em>Inc</em>.’s Google. That effort has faced headwinds in recent quarters as growth rates slowed.\n\n(BNN Bloomberg)\n\nVancouver-based developer operations platform Codezero has secured $3.5 million in seed funding.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "72ced867-13af-416c-b9ad-be4e3d2baf09",
"title": "AstraZeneca: acquisition of Fusion in precision oncology -March 19, 2024 at 05:01 am EDT",
"description": "AstraZeneca announced on Tuesday that it would take control of Canadian precision cancer drugs company Fusion Pharmaceuticals in a deal worth up to $2.4 billion.Through this acquisition, the...",
"keywords": "Markets",
"snippet": "AstraZeneca: acquisition of Fusion in precision oncology\n\nMarch 19, 2024 at 05:01 am EDT Share\n\nAstraZeneca announced on Tuesday that it would take control of C...",
"url": "https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-acquisition-of-Fusion-in-precision-oncology-46228535/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2024-03-19T09:01:50.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.14682,
"sentiment_score": 0.117433,
"highlights": [
{
"highlight": "<em>AstraZeneca</em>: acquisition of Fusion in precision oncology\n\nMarch 19, 2024 at 05:01 am EDT Share\n\n<em>AstraZeneca</em> announced on Tuesday that it would take control of Canadian precision cancer drugs company Fusion Pharmaceuticals in a deal worth up to $2.4 billion.",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "In detail, <em>AstraZeneca</em> will offer $21 per share in cash to shareholders of Nasdaq-listed Fusion Pharmaceuticals, compared with a closing price of $10.6 last night.\n\n\n\nThe deal, estimated at $2 billion, could rise to $2.4 billion with the payment of an additional $3 per share if certain regulatory milestones are met.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em>: acquisition of Fusion in precision oncology -March 19, 2024 at 05:01 am EDT",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 2149,
"sentiment_avg": 0.3121851532447497
}
]
}
Other details
Country
- us
- 5,275